메뉴 건너뛰기




Volumn 55, Issue 10, 2012, Pages 4776-4787

Rapid identification of a novel small molecule phosphodiesterase 10A (PDE10A) tracer

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 AMINO 4 FLUORO 5 METHOXYPHENYL)ETHANONE; 1 (4 FLUORO 5 METHOXY 2 NITROPHENYL)ETHANONE; 2 [4 [1 METHYL 4 (4 PYRIDINYL) 3 PYRAZOLYL]PHENOXYMETHYL]QUINOLINE; 4 (6 FLUORO 5 METHYLPYRIDIN 3 YL) 6 METHOXYCINNOLIN 7 OL; 4 (6 FLUORO 5 METHYLPYRIDIN 3 YL) 6,7 DIMETHOXYCINNOLINE; 4 BROMO 6,7 DIMETHOXYCINNOLINE; 4 BROMO 7 FLUORO 6 METHOXYCINNOLINE; 5 (6,7 DIMETHOXYCINNOLIN 4 YL) 3 METHYL N [1 (PYRIDIN 2 YL)PROPAN 2 YL]PYRIDIN 2 AMINE; 5 (6,7 DIMETHOXYCINNOLIN 4 YL) N ISOPROPYL 3 METHYLPYRIDIN 2 AMINE; 5 [6,7 [3H]DIMETHOXYCINNOLIN 4 YL] N ISOPROPYL 3 METHYLPYRIDIN 2 AMINE[[3H]5]; 6,7 DIMETHOXYCINNOLIN 4 OL; 7 (BENZYLOXY) 4 (6 FLUORO 5 METHYLPYRIDIN 3 YL) 6 METHOXYCINNOLINE; 7 (BENZYLOXY) 4 BROMO 6 METHOXYCINNOLINE; 7 FLUORO 6 METHOXYCINNOLIN 4 OL; AMG 7980; N (2,2 DIFLUOROETHYL) 5 (6,7 DIMETHOXYCINNOLIN 4 YL) N ETHYL 3 METHYLPYRIDIN 2 AMINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 10A; RECOMBINANT ENZYME; RECOMBINANT PHOSPHODIESTERASE 10A; TRACER; UNCLASSIFIED DRUG;

EID: 84861491053     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3002372     Document Type: Article
Times cited : (29)

References (40)
  • 1
    • 33745050401 scopus 로고    scopus 로고
    • Using positron emission tomography to facilitate CNS drug development
    • Lee, C.; Parde, L. Using positron emission tomography to facilitate CNS drug development Trends Pharmacol. Sci. 2006, 27, 310-317
    • (2006) Trends Pharmacol. Sci. , vol.27 , pp. 310-317
    • Lee, C.1    Parde, L.2
  • 2
    • 57649136969 scopus 로고    scopus 로고
    • The role of imaging in proof of concept for CNS drug discovery and development
    • Wong, D. F.; Tauscher, J.; Grunder, G. The role of imaging in proof of concept for CNS drug discovery and development Neuropsychopharmacology. 2009, 34, 187-203
    • (2009) Neuropsychopharmacology. , vol.34 , pp. 187-203
    • Wong, D.F.1    Tauscher, J.2    Grunder, G.3
  • 3
    • 38349095953 scopus 로고    scopus 로고
    • The role of molecular imaging in drug discovery and development
    • Hargreaves, R. J. The role of molecular imaging in drug discovery and development Clin. Pharmacol. Ther. 2008, 83, 349-353
    • (2008) Clin. Pharmacol. Ther. , vol.83 , pp. 349-353
    • Hargreaves, R.J.1
  • 5
    • 34447265905 scopus 로고    scopus 로고
    • Biochemistry and physiology of cyclic nucleotide phosphodiesterases: Essential components in cyclic nucleotide signaling
    • Conti, M.; Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling Annu. Rev. Biochem. 2007, 76, 481-511
    • (2007) Annu. Rev. Biochem. , vol.76 , pp. 481-511
    • Conti, M.1    Beavo, J.2
  • 8
    • 77956925425 scopus 로고    scopus 로고
    • Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
    • Lakics, V.; Karran, E. H.; Boess, F. G. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues Neuropharmacology 2010, 59, 367-374
    • (2010) Neuropharmacology , vol.59 , pp. 367-374
    • Lakics, V.1    Karran, E.H.2    Boess, F.G.3
  • 10
    • 38149121389 scopus 로고    scopus 로고
    • Behavioral characterization of mice deficient in the phosphodiesterase- 10A (PDE10A) enzyme on a C57/Bl6N congenic background
    • Siuciak, J.; McCarthy, S.; Chapin, D.; Martin, A.; Harms, J.; Schmidt, C. Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background Neuropharmacology 2007, 54, 417-427
    • (2007) Neuropharmacology , vol.54 , pp. 417-427
    • Siuciak, J.1    McCarthy, S.2    Chapin, D.3    Martin, A.4    Harms, J.5    Schmidt, C.6
  • 12
    • 33847022578 scopus 로고    scopus 로고
    • The potential therapeutic use of phosphodiesterase 10 inhibitors
    • Kehler, J.; Ritzén, A.; Greve, D. The potential therapeutic use of phosphodiesterase 10 inhibitors Expert Opin. Ther. Pat. 2007, 17, 147-158
    • (2007) Expert Opin. Ther. Pat. , vol.17 , pp. 147-158
    • Kehler, J.1    Ritzén, A.2    Greve, D.3
  • 15
    • 0023853769 scopus 로고
    • Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
    • Farde, L.; Wiesel, F.; Halldin, C.; Sedval, G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs Arch. Gen. Psychiatry 1988, 45, 71-76 (Pubitemid 18018572)
    • (1988) Archives of General Psychiatry , vol.45 , Issue.1 , pp. 71-76
    • Farde, L.1    Wiesel, F.-A.2    Halldin, C.3    Sedvall, G.4
  • 16
    • 64149113053 scopus 로고    scopus 로고
    • Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dapaminergic system to D-amphetamine: Involvement of the D1-regulated feedback control of midbrain dopamine neurons
    • Sotty, F.; Montezinho, L.; Steiniger-Brach, B.; Nielson, J. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dapaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons J. Neurochem. 2009, 109, 766-775
    • (2009) J. Neurochem. , vol.109 , pp. 766-775
    • Sotty, F.1    Montezinho, L.2    Steiniger-Brach, B.3    Nielson, J.4
  • 17
    • 12344326514 scopus 로고    scopus 로고
    • Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs
    • DOI 10.1038/sj.mp.4001556
    • Miyamoto, S.; Duncan, G. E.; Marx, C. E.; Lieberman, J. A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol. Psychiatry 2005, 10, 79-104 (Pubitemid 40139590)
    • (2005) Molecular Psychiatry , vol.10 , Issue.1 , pp. 79-104
    • Miyamoto, S.1    Duncan, G.E.2    Marx, C.E.3    Lieberman, J.A.4
  • 18
    • 77649092400 scopus 로고    scopus 로고
    • A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia
    • Simpson, E. H.; Kellendonk, C.; Kandel, E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia Neuron 2010, 65, 585-596
    • (2010) Neuron , vol.65 , pp. 585-596
    • Simpson, E.H.1    Kellendonk, C.2    Kandel, E.3
  • 19
    • 33847022578 scopus 로고    scopus 로고
    • The potential therapeutic use of phosphodiesterase 10 inhibitors
    • Kehler, A. R.; Greve, D. R. The potential therapeutic use of phosphodiesterase 10 inhibitors Expert Opin. Ther. Pat. 2007, 17, 147-158
    • (2007) Expert Opin. Ther. Pat. , vol.17 , pp. 147-158
    • Kehler, A.R.1    Greve, D.R.2
  • 20
    • 33846975147 scopus 로고    scopus 로고
    • Role of phosphodiesterases in neurological and psychiatric disease
    • DOI 10.1016/j.coph.2006.08.014, PII S1471489206001950, Neurosciences
    • Hebb, A. L.; Robertson, H. A. Role of phosphodiesterases in neurological and psychiatric disease Curr. Opin. Pharmacol. 2007, 7, 86-92 (Pubitemid 46242039)
    • (2007) Current Opinion in Pharmacology , vol.7 , Issue.1 , pp. 86-92
    • Hebb, A.L.1    Robertson, H.A.2
  • 22
    • 33746629480 scopus 로고    scopus 로고
    • Phosphodiesterases in the CNS: Targets for drug development
    • Menniti, F. S.; Faraci, W. S.; Schmidt, C. J. Phosphodiesterases in the CNS: targets for drug development Nat. Rev. Drug Discovery 2006, 5, 661-670
    • (2006) Nat. Rev. Drug Discovery , vol.5 , pp. 661-670
    • Menniti, F.S.1    Faraci, W.S.2    Schmidt, C.J.3
  • 23
    • 35148895860 scopus 로고    scopus 로고
    • PDE inhibitors in psychiatry - future options for dementia, depression and schizophrenia?
    • DOI 10.1016/j.drudis.2007.07.023, PII S1359644607003066
    • Halene, T. B.; Siegel, S. J. PDE Inhibitors in psychiatry-future options for dementia, depression and schizophrenia? Drug Discovery Today 2007, 12, 870-878 (Pubitemid 47539966)
    • (2007) Drug Discovery Today , vol.12 , Issue.19-20 , pp. 870-878
    • Halene, T.B.1    Siegel, S.J.2
  • 24
    • 33748686575 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
    • DOI 10.1124/pr.58.3.5
    • Bender, A. T.; Beavo, J. A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacol. Rev. 2006, 58, 488-520 (Pubitemid 44394910)
    • (2006) Pharmacological Reviews , vol.58 , Issue.3 , pp. 488-520
    • Bender, A.T.1    Beavo, J.A.2
  • 25
    • 78650779872 scopus 로고    scopus 로고
    • Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntingont's disease
    • Kleiman, R. J.; Kimmel, L. H.; Bove, S. E.; Lanz, T. A.; Harms, J. F.; Romegialli, A.; Miller, K. S.; Willis, A.; des Etages, S.; Kuhn, M.; Schmidt, C. J. Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntingont's disease J. Pharmacol. Exp. Ther. 2011, 336, 64-76
    • (2011) J. Pharmacol. Exp. Ther. , vol.336 , pp. 64-76
    • Kleiman, R.J.1    Kimmel, L.H.2    Bove, S.E.3    Lanz, T.A.4    Harms, J.F.5    Romegialli, A.6    Miller, K.S.7    Willis, A.8    Des Etages, S.9    Kuhn, M.10    Schmidt, C.J.11
  • 26
    • 72049086425 scopus 로고    scopus 로고
    • Alterations in gene regulations following inhibition of the striatum-enriched phosphodiesterase, PDE10A
    • Strick, C. A.; James, L. C.; Fox, C. B.; Seeger, T. F.; Menniti, F. S.; Schmidt, C. J. Alterations in gene regulations following inhibition of the striatum-enriched phosphodiesterase, PDE10A Neuropharmacology 2010, 58, 444-451
    • (2010) Neuropharmacology , vol.58 , pp. 444-451
    • Strick, C.A.1    James, L.C.2    Fox, C.B.3    Seeger, T.F.4    Menniti, F.S.5    Schmidt, C.J.6
  • 27
    • 33646180173 scopus 로고    scopus 로고
    • Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measuredusing radiolabeled or nonlabeled raclopride
    • Barth, V.; Chernet, E.; Martin, L.; Need, A.; Rash, K.; Morin, M.; Phebus, L. A. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measuredusing radiolabeled or nonlabeled raclopride Life Sci. 2006, 78, 3007-3012
    • (2006) Life Sci. , vol.78 , pp. 3007-3012
    • Barth, V.1    Chernet, E.2    Martin, L.3    Need, A.4    Rash, K.5    Morin, M.6    Phebus, L.A.7
  • 28
    • 35348996615 scopus 로고    scopus 로고
    • In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously
    • DOI 10.1016/j.lfs.2007.09.005, PII S0024320507006662
    • Need, A. B.; McKinzie, J, H.; Mitch, C. H.; Statnick, M. A.; Phebus, L. A. In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously Life Sci. 2007, 81, 1389-1396 (Pubitemid 47603187)
    • (2007) Life Sciences , vol.81 , Issue.17-18 , pp. 1389-1396
    • Need, A.B.1    McKinzie, J.H.2    Mitch, C.H.3    Statnick, M.A.4    Phebus, L.A.5
  • 29
    • 27744530843 scopus 로고    scopus 로고
    • Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: Dopamine D2, serotonin 2A and NK-1 receptors as examples
    • DOI 10.1016/j.lfs.2005.04.075, PII S0024320505007915
    • Chernet, E.; Martin, L. J.; Li, D.; Need, A. B.; Barth, V. N.; Rash, K. S.; Phebus, L. A. Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples Life Sci. 2005, 78, 340-346 (Pubitemid 41599770)
    • (2005) Life Sciences , vol.78 , Issue.4 , pp. 340-346
    • Chernet, E.1    Martin, L.J.2    Li, D.3    Need, A.B.4    Barth, V.N.5    Rash, K.S.6    Phebus, L.A.7
  • 32
    • 0036386982 scopus 로고    scopus 로고
    • Measuring drug-related receptor occupancy with positron emission tomography
    • Passchier, J.; Gee, A.; Willemsen, A.; Vaalburg, W.; van Waarde, A. Measuring drug-related receptor occupancy with positron emission tomography Methods 2002, 27, 278-286
    • (2002) Methods , vol.27 , pp. 278-286
    • Passchier, J.1    Gee, A.2    Willemsen, A.3    Vaalburg, W.4    Van Waarde, A.5
  • 33
    • 0344121285 scopus 로고    scopus 로고
    • Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems
    • DOI 10.1016/j.mibio.2003.09.011, PII S1536163203001690
    • Wong, D. F.; Pomper, M. G. Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems Mol. Imaging Biol. 2003, 5, 350-362 (Pubitemid 37489826)
    • (2003) Molecular Imaging and Biology , vol.5 , Issue.6 , pp. 350-362
    • Wong, D.F.1    Pomper, M.G.2
  • 34
    • 2542490139 scopus 로고    scopus 로고
    • PET tracer and radiochemistry
    • Schlyer, D. PET tracer and radiochemistry Ann. Acad. Med., Singapore 2004, 33, 146-154
    • (2004) Ann. Acad. Med., Singapore , vol.33 , pp. 146-154
    • Schlyer, D.1
  • 35
    • 0015861774 scopus 로고
    • Relationshiop between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction
    • Cheng, Y; Prusoff, W. H. Relationshiop between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
    • (1973) Biochem. Pharmacol. , vol.22 , pp. 3099-3108
    • Cheng, Y.1    Prusoff, W.H.2
  • 38
    • 0028825399 scopus 로고
    • Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
    • Schinkel, A. H.; Wagenaar, E.; van Deemter, L.; Mol, C. A.; Borst, P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A J. Clin. Invest. 1995, 96, 1698-1705
    • (1995) J. Clin. Invest. , vol.96 , pp. 1698-1705
    • Schinkel, A.H.1    Wagenaar, E.2    Van Deemter, L.3    Mol, C.A.4    Borst, P.5
  • 39
    • 31144460354 scopus 로고    scopus 로고
    • Analyzing a kinetic titration series using affinity biosensors
    • DOI 10.1016/j.ab.2005.09.034, PII S0003269705006986
    • Karlsson, R.; Katsamba, P. S.; Nordin, H.; Pol, E.; Myszka, D. G. Analyzing a kinetic titration series using affinity biosensors Anal. Biochem. 2006, 349, 136-147 (Pubitemid 43129567)
    • (2006) Analytical Biochemistry , vol.349 , Issue.1 , pp. 136-147
    • Karlsson, R.1    Katsamba, P.S.2    Nordin, H.3    Pol, E.4    Myszka, D.G.5
  • 40
    • 0034783501 scopus 로고    scopus 로고
    • 2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects
    • DOI 10.1016/S0893-133X(01)00261-5, PII S0893133X01002615
    • Wadenberg, M.; Soliman, A.; VanderSpek, S. C.; Kapur, S. Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects Neuropsychopharmacology 2001, 25, 633-641 (Pubitemid 32995945)
    • (2001) Neuropsychopharmacology , vol.25 , Issue.5 , pp. 633-641
    • Wadenberg, M.-L.G.1    Soliman, A.2    VanderSpek, S.C.3    Kapur, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.